Minami Nutrition is about proof NOT promises. Our product range are produced as a result of our committment to research that examines the effect of Omega-3 fats on a variety of medical areas, including Dyslexia, Dyspraxia, Attention Deficit Hyperactivity Disorder (AD/HD) as well as Heart Disease and Wellness issues.

Clinical studies show that Omega-3 fatty acids are well tolerated by children and adults. The general consensus is that 1 g of EPA + DHA per day is sufficient to maintain optimum performance of the cardiovascular system in most people.*

Ongoing scientific research is revealing more about the enormous potential for Omega-3 fatty acids to positively impact on a range of health outcomes.*

Heart and Cardiovascular Disease*:
Prevention = 1 g EPA + DHA/day (1,2)
With high blood triglycerides = 2 to 4 g EPA + DHA/day (1)

Attention Deficit Hyperactivity Disorder (AD/HD), Dyslexia, Dyspraxia*:
0.5 to 1 g EPA/day (8)

Depression and Bipolar Disorder*:
1 to 2 g EPA/day as supplementary treatment with standard therapy (3-5)

Schizophrenia*:
2 g EPA/day as supplementary treatment with standard therapy (6)

Mood Disorder (aggression)*:
1 to 2 g EPA/day (7)

Pregnancy and Breast Feeding*:
220 to 800 mg EPA/day and 300 mg to 1 g DHA/day (9-11)

Brain and Visual Development*:
20-40 mg DHA/2.2 lb. body weight/day12